Last reviewed · How we verify

NCT07436780: OLYMPE

B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP (Ventilator-Associated Pneumonia)

Not yet recruiting Last updated 27 February 2026
What this trial tests

trial in Ventilator-associated Pneumonia in 75 participants. Not yet recruiting.

Timeline
31 January 2026
Primary endpoint
30 July 2027
30 July 2027

Quick facts

Lead sponsorUniversity Hospital, Limoges
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment75
Start date31 January 2026
Primary completion30 July 2027
Estimated completion30 July 2027

Conditions studied

Sponsor

University Hospital, Limoges

Who can join

18 and older, any sex, with Ventilator-associated Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diagnosis of VAP relies on a set of non-specific clinical, biological, and imaging criteria. Understanding host-pathogen interactions and the mechanisms of deregulations leading to infection of pulmonary tissue appears essential. The aim is to qualitatively describe the B lymphocyte populations present in the pulmonary microenvironment of patients admitted to intensive care and requiring invasive mechanical ventilation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Limoges trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07436780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing